Early research (Phase 1)Study completedNCT04627064What this trial is testingABEMA Alone or in COMBO With MK-6482Who this might be right forClear Cell Renal Cell Carcinoma Dana-Farber Cancer Institute 11
Not applicableLooking for participantsNCT00001238What this trial is testingVon Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant DisordersWho this might be right forKidney CancerUrologic Malignant DisordersRenal Cell Carcinoma+2 more National Cancer Institute (NCI) 5,000
Not applicableStudy completedNCT00900536What this trial is testingDNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCEWho this might be right forKidney Cancer Medical Research Council
Testing effectiveness (Phase 2)Study completedNCT01408004What this trial is testingRotating Pazopanib and Everolimus to Avoid ResistanceWho this might be right forClear Cell Renal Carcinoma Netherlands Working Group on Immunotherapy of Oncology 101
Testing effectiveness (Phase 2)Study completedNCT00416455What this trial is testingFludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial CancerWho this might be right forCervical AdenocarcinomaCervical Adenosquamous Cell CarcinomaCervical Small Cell Carcinoma+11 more National Cancer Institute (NCI) 384
Testing effectiveness (Phase 2)Ended earlyNCT02089334What this trial is testingDose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell CancerWho this might be right forMetastatic Renal Cell Cancer Rexahn Pharmaceuticals, Inc. 24
Early research (Phase 1)Not Yet RecruitingNCT07768306What this trial is testingEvaluation of Safety, Pharmacokinetics, Distribution，Radiation Safety and Sensitivity/Specificity of PET/CT Imaging With 68Ga-NYM096 in Participants With IRMWho this might be right forClear Cell Renal Cell Carcinoma (ccRCC) Norroy Bioscience Co., LTD 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT01038778What this trial is testingEntinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage III Renal Cell Cancer AJCC v7+1 more National Cancer Institute (NCI) 47
Large-scale testing (Phase 3)Study completedNCT00262847What this trial is testingCarboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerWho this might be right forFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+24 more National Cancer Institute (NCI) 1,873
Not applicableLooking for participantsNCT04053855What this trial is testingEvaluation of Urinary Exosomes Presence From Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma Centre Hospitalier Universitaire de Saint Etienne 100
Early research (Phase 1)Study completedNCT00004178What this trial is testingGene Therapy in Treating Patients With CancerWho this might be right forCancer Roger Williams Medical Center
Early research (Phase 1)Study completedNCT00003385What this trial is testingCombination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Gynecologic Oncology Group 48
Testing effectiveness (Phase 2)Ended earlyNCT04300140What this trial is testingSafety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma Aravive, Inc. 72
Early research (Phase 1)Ended earlyNCT02837991What this trial is testingA Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell CarcinomaWho this might be right forRenal Cell Carcinoma (RCC)Clear-cell Renal Cell CarcinomaPapillary Renal Cell Carcinoma+3 more Celldex Therapeutics 16
Testing effectiveness (Phase 2)Ended earlyNCT00354601What this trial is testingDocetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity CancerWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer Wake Forest University Health Sciences 2
Testing effectiveness (Phase 2)Study completedNCT00566995What this trial is testingPhase II Study of Vandetanib in Individuals With Kidney CancerWho this might be right forRenal CancerVon Hippel Lindau National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT01034878What this trial is testingSunitinib in Metastatic Renal CancerWho this might be right forCarcinoma, Renal Cell Istituto Clinico Humanitas 25
Testing effectiveness (Phase 2)Study completedNCT00003127What this trial is testingS9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial CancerWho this might be right forEndometrial Cancer SWOG Cancer Research Network 57
Early research (Phase 1)Ended earlyNCT00623077What this trial is testingMT2004-30: Tomotherapy for Solid TumorsWho this might be right forBrain and Central Nervous System TumorsKidney CancerLiver Cancer+2 more Masonic Cancer Center, University of Minnesota 23
Large-scale testing (Phase 3)Active Not RecruitingNCT01167712What this trial is testingPaclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerWho this might be right forFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Transitional Cell Carcinoma+27 more National Cancer Institute (NCI) 692